Implikationen der genetischen Beratung bei Hochrisiko-Familien für erblichen Brust- und Eierstockkrebs

  • Brigitte Schlegelberger
  • Ulrich Hoffrage


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. American Society of Clinical Oncology (ASCO) (1996) Statement of the American Society of Clinical Oncology: Genetic testing for cancer susceptibility. J Clin Oncol 14: 1730–36.Google Scholar
  2. Berry DA, Parmigiani G, Sanchez J, Schildkraut J, Winer E. (1997) Probability of carrying a mutation of breast-ovarian cancer gene BRCA1 based on family history. J Nat Cancer Inst 89: 227–38.CrossRefPubMedGoogle Scholar
  3. Bottorff JL, Ratner PA, Johnson JL, Lovato CY, Joab SA. (1998) Communicating cancer risk information: the challenges of uncertainty. Patient Educ Couns 33: 67–81.PubMedGoogle Scholar
  4. Brain K, Gray J, Norman P, Parsons E, Clarke A, Rogers C, Mansel R, Harper P. (2000) Why do women attend familial breast cancer clinics? J Med Genet 37: 197–202.CrossRefPubMedGoogle Scholar
  5. Bundesärztekammer. (1998) Richtlinien zur Diagnostik der genetischen Disposition für Krebserkrankungen. Dt Ärztebl 95: A1396–1403.Google Scholar
  6. BVmedgen und GfH. (1996a) Richtlinien und Stellungnahmen: Leitlinien zur Genetischen Beratung. medgen 8:Bl 1–2.Google Scholar
  7. BVmedgen und GfH. (1995) Richtlinien und Stellungnahmen: Stellungnahme zur Entdeckung des Brustkrebsgens BRCA1. medgen 7: 8–10.Google Scholar
  8. Chang-Claude J, Becher H, Hamann U, Schroeder-Kurth T. (1995) Risikoabschätzung für das familiäre Auftreten von Brustkrebs. Zentralbl Gynäkol 117: 423–34.PubMedGoogle Scholar
  9. Claus EB, Risch N, Thompson WD. (1991) Genetic analysis of breast cancer in the Cancer and Steroid Hormone Study. Am J Hum Genet 48: 232–42.PubMedGoogle Scholar
  10. Claus EB, Schildkraut JM, Thompson WD, Risch N. (1996) The genetic attributable risk of breast and ovarian cancer. Cancer 77:2318–24.CrossRefPubMedGoogle Scholar
  11. Collaborative Group on Hormonal Factors in Breast Cancer (2001) Familial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58 209 women with breast cancer and 101 986 women without the disease. Lancet 358: 1389–99.Google Scholar
  12. Croyle RT, Lerman C. (1999) Risk communication in genetic testing for cancer susceptibility. J Nat Cancer Inst Mon 25: 59–66.Google Scholar
  13. Davison C, Macintyre S, Smith GD. (1994) The potential social impact of predictive genetic testing for susceptibility to common chronic diseases: a review and proposed research agenda. Sociol Health Ill 16:341–71.Google Scholar
  14. Decruyenaere M, Evers-Kiebooms G, Denayer L, Welkenhuysen M, Claes E, Legius E, Demyttenaere K. (2000) Predictive testing for hereditary breast and ovarian cancer: a psychological framework for pre-test counselling. Eur J Hum Genet 8: 130–6.CrossRefPubMedGoogle Scholar
  15. Easton DF, Ford D, Bishop DT, and the Breast Cancer Linkage Consortium. (1995) Breast and ovarian cancer incidence in BRCA1-mutation carriers. Am J Hum Genet 56: 265–71.PubMedGoogle Scholar
  16. Eisinger F, Alby N, Bremond A et al. (1998) Recommendations for medical management of hereditary breast and ovarian cancer: The French National Ad Hoc Committee. Ann Oncol 9: 939–50.CrossRefPubMedGoogle Scholar
  17. Euhus DM, Smith KC, Robinson L et al. (2002) Pretest prediction of BRCA1 or BRCA2 mutation by risk counselors and the computer model BRCAPRO. J Nat Cancer Inst 94: 844–51.PubMedGoogle Scholar
  18. Evers-Kiebooms G, Welkenhuysen M, Claes E, Decruyenaere M, Denayer L. (2000) The psychological complexity of predictive testing for late onset neurogenetic diseases and hereditary cancers: Implications for multidisciplinary counselling and for genetic education. Soc Sci Med 5: 831–41.Google Scholar
  19. Ford D, Easton DF, Peto J. (1995) Estimates of the gene frequency of BRCA1 and its contribution to breast and ovarian cancer incidence. Am J Hum Genet 57: 1457–62.PubMedGoogle Scholar
  20. Gail MH, Brinton LA, Byar DP, Corle DK, Gree SB, Schairer C, Mulvihill JJ. (1989) Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Nat Cancer Inst 81: 1879–86.PubMedGoogle Scholar
  21. Gigerenzer G, Hoffrage U, Ebert A. (1998) AIDS counseling for low-risk clients. Aids Care 10: 197–211.PubMedGoogle Scholar
  22. Green J, Richards M, Murton F, Statham H, Hallowell N. (1997) Family communication and genetic counseling: the case of hereditary breast and ovarian cancer. J Genet Couns 6: 45–60.Google Scholar
  23. Hallowell N, Murton F, Statham H, Green JM, Richards MP. (1997a) Women’s need for information before attending genetic counselling for familial breast or ovarian cancer: a questionnaire, interview and observational study. BMJ 314: 281–3.PubMedGoogle Scholar
  24. Hallowell N, Statham H, Murton F, Green J, Richards M. (1997b) „Talking about chance“. The presentation of risk information during genetic counseling for breast and ovarian cancer. J Genet Couns 6: 269–86.Google Scholar
  25. Hallowell N, Murton F. (1998) The value of written summaries of genetic consultations. Patient Educ Couns 35: 27–34.PubMedGoogle Scholar
  26. Hoffrage U, Lindsey S, Hertwig R, Gigerenzer G. (2000) Communicating statistical information. Science 290: 2261–62.CrossRefPubMedGoogle Scholar
  27. Jernström H, Lerman C, Chadirian P et al. (1999) Pregnancy and risk of early breast cancer in carriers of BRCA1 and BRCA2. Lancet 354: 1846–50.PubMedGoogle Scholar
  28. Julian-Reynier C, Eisinger F, Chabal F, Lasset C, Noguès C, Stoppa-Lyonnet D, Vennin P, Sobol H. (2000) Disclosure to the family of breast/ovarian cancer genetic test results: patient’s willingness and associated factors. Am J Med Genet 94: 13–18.CrossRefPubMedGoogle Scholar
  29. Kerr B, Foulkes WD, Cade D, Hadfield L, Hopwood P, Serruya C, Hoare E, Narod SA, Evans DG. (1998) False family history of breast cancer in the family cancer clinic. Eur J Surg Oncol 24: 275–9.CrossRefPubMedGoogle Scholar
  30. King M-C, Marks JH, Mandell JB for The New York Breast Cancer Study Group. (2003) Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2. Science 302:643–6.CrossRefPubMedGoogle Scholar
  31. Kuehberger A. (1998) The influence of framing on risky decisions: A meta-analysis. Organ Behav Hum Decision Proc 75: 23–55.Google Scholar
  32. Leggatt V, Mackay J, Yates JR. (1999) Evaluation of questionnaire on cancer family history in identifying patients at increased genetic risk in general practice. BMJ 319: 757–8.PubMedGoogle Scholar
  33. Lerman C, Hughes C, Lemon SJ, Main D, Snyder C, Durham C, Narod S, Lynch HT. (1998) What you don’t know can hurt you: adverse psychologic effects in members of BRCA1-linked and BRCA2-linked families who decline genetic testing. J Clin Oncol 16: 1639–41.Google Scholar
  34. Lerman C, Croyle RT, Tercyak KP, Hamann H. (2002) Genetic testing: Psychological aspects and implications. J Consult Clin Psychol 70: 784–97.PubMedGoogle Scholar
  35. Lodder LN, Frets PG, Trijsburg RW et al. (1999) Presymptomatic testing for BRCA1 and BRCA2: how distressing are the pre-test weeks? Rotterdam/Leiden Genetics Working Group. J Med Genet 36: 906–13.PubMedGoogle Scholar
  36. Lynch HT, Lemon SJ, Durham C et al. (1997) A descriptive study of BRCA1 testing and reactions to disclosure of test results. Cancer 79: 2219–28).PubMedGoogle Scholar
  37. Lynch HT, Watson P, Tinley S et al. (1999) An update on DNA-based BRCA1/BRCA2 genetic counseling in hereditary breast cancer. Cancer Genet Cytogenet 109: 91–98.CrossRefPubMedGoogle Scholar
  38. Meiser B, Halliday JL. (2002) What is the impact of genetic counselling in women at increased risk of developing hereditary breast cancer? A meta-analytic review. Soc Sci Med 54: 1463–70.CrossRefPubMedGoogle Scholar
  39. Metcalfe KA, Liede A, Hoodfar E, Scott A, Foulkes WD, Narod SA. (2003) An evaluation of needs of female BRCA1 and BRCA2 carriers undergoing genetic counselling. J Med Genet 37: 866–74.Google Scholar
  40. National Institute for Clinical Excellence, London. (2004) NICE Clinical Guideline 14: Familial breast cancer. The classification and care of women at risk of familial breast cancer in primary, secondary and tertiary care.Google Scholar
  41. Nippert I, Schlegelberger B and the members of the Consortium „Hereditary Breast and Ovarian Can-cer of the Deutsche Krebshilfe (2003) Women’s experiences of undergoing BRCA1 and BRCA2 testing: organization of the German Hereditary Breast and Ovarian Cancer Consortium survey and preliminary data from Münster. Community Genet 6: 249–258.CrossRefPubMedGoogle Scholar
  42. Parmigiani G, Berry DA, Aguilar O. (1998) Determining carrier probabilities for breast cancer-susceptibility genes BRCA1 and BRCA2. Am J Hum Genet 62: 145–58.CrossRefPubMedGoogle Scholar
  43. Pearn JH, (1973) Patients’ subjective interpretation of risks offered in genetic counselling. J Med Genet 10: 129–34.PubMedGoogle Scholar
  44. Sachs L, Taube A, Tishelman C. (2001) Risk in numbers — difficulties in the transformation of genetic knowledge from research to people — the case of hereditary cancer. Acta Oncol 40: 445–453.PubMedGoogle Scholar
  45. Schmutzler R, Schlegelberger B, Meindl A, Gerber W-D, Kiechle M. (2003) Beratung, genetische Testung und Prävention von Frauen mit einer familiären Belastung für das Mamma-und Ovarialkarzinom. Interdisziplinäre Empfehlungen des Verbundprojektes „Familiärer Brust-und Eierstockkrebs“ der Deutschen Krebshilfe. medgen 15: 385–395.Google Scholar
  46. Welkenhuysen M, Evers-Kiebooms G, d’Ydewalle G. (2001) The language of uncertainty in genetic risk communication: Framing and verbal versus numerical information. Patient Educ Couns 43: 179–87.PubMedGoogle Scholar

Copyright information

© Springer Medizin Verlag Heidelberg 2005

Authors and Affiliations

  • Brigitte Schlegelberger
    • 1
  • Ulrich Hoffrage
    • 2
    • 3
  1. 1.Abteilung für Zell- und MolekularpathologieMedizinische Hochschule HannoverHannover
  2. 2.Zentrum für Adaptives Verhalten und KognitionMax-Planck-Institut für BildungsforschungBerlin
  3. 3.Ecole des Hautes Etudes Commerciales (HEC)Université de Lausanne, BFSH 1Lausanne

Personalised recommendations